Mount Sinai to utilize AI for cardiovascular care

To better use technology to treat congestive heart failure, New York’s Mount Sinai Hospital has plans to use CloudMedx Clinical AI Platform, an artificial intelligence services software, reports Fortune.

The facility plans to use the software to help monitor patients after they leave the hospital to prevent unnecessary readmissions. CloudMedx can store electronic health records, giving improved accessibility for physicians, nurses and administrators.

“We need tools to mine text data to figure out who needs the most proactive care and CloudMedx helps there,” said Ashish Atreja, chief technology innovation and engagement officer for medicine at Mount Sinai’s Icahn School of Medicine.

To read more about how Mount Sinai is incorporating AI into their practice, follow the link below:

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.